Related Experiment Video
Updated: Jul 26, 2025

Separating Bacteria by Capsule Amount Using a Discontinuous Density Gradient
Published on: January 7, 2019
Phages against Noncapsulated Klebsiella pneumoniae: Broader Host range, Slower Resistance
Marta Lourenço1, Lisa Osbelt2,3, Virginie Passet1
1Institut Pasteur, Université Paris Cité, Biodiversity and Epidemiology of Bacterial Pathogens, Paris, France.
Abstract:
Klebsiella pneumoniae (Kp), a human gut colonizer and opportunistic pathogen, is a major contributor to the global burden of antimicrobial resistance. Virulent bacteriophages represent promising agents for decolonization and therapy. However, the majority of anti-Kp phages that have been isolated thus far are highly specific to unique capsular types (anti-K phages), which is a major limitation to phage therapy prospects due to the highly polymorphic capsule of Kp. Here, we report on an original anti-Kp phage isolation strategy, using capsule-deficient Kp mutants as hosts (anti-Kd phages). We show that anti-Kd phages have a broad host range, as the majority are able to infect noncapsulated mutants of multiple genetic sublineages and O-types. Additionally, anti-Kd phages induce a lower rate of resistance emergence in vitro and provide increased killing efficiency when in combination with anti-K phages. In vivo, anti-Kd phages are able to replicate in mouse guts colonized with a capsulated Kp strain, suggesting the presence of noncapsulated Kp subpopulations. The original strategy proposed here represents a promising avenue that circumvents the Kp capsule host restriction barrier, offering promise for therapeutic development. IMPORTANCE Klebsiella pneumoniae (Kp) is an ecologically generalist bacterium as well as an opportunistic pathogen that is responsible for hospital-acquired infections and a major contributor to the global burden of antimicrobial resistance. In the last decades, limited advances have been made in the use of virulent phages as alternatives or complements to antibiotics that are used to treat Kp infections. This work demonstrates the potential value of an anti-Klebsiella phage isolation strategy that addresses the issue of the narrow host range of anti-K phages. Anti-Kd phages may be active in infection sites in which capsule expression is intermittent or repressed or in combination with anti-K phages, which often induce the loss of capsule in escape mutants.
Insights
New bacteriophages targeting capsule-deficient Klebsiella pneumoniae (Kp) show broad host range and potential for phage therapy. These anti-Kd phages overcome limitations of capsule-specific phages, offering a promising strategy against antimicrobial resistance.
Area of Science:
- Microbiology
- Bacteriology
- Phage Therapy
Background:
- Klebsiella pneumoniae (Kp) is a significant cause of hospital-acquired infections and antimicrobial resistance.
- Current phage therapy for Kp is limited by phage specificity to capsular types.
- The polymorphic capsule of Kp poses a major barrier to effective phage therapy.
Purpose of the Study:
- To develop a novel strategy for isolating broad-host-range anti-Kp phages.
- To overcome the capsule-mediated host restriction in Klebsiella pneumoniae.
- To evaluate the therapeutic potential of newly isolated phages.
Main Methods:
- Isolation of anti-Kp phages using capsule-deficient Kp mutants as hosts (anti-Kd phages).
- Assessment of phage host range against various Kp genetic sublineages and O-types.
- Evaluation of phage efficacy in vitro (resistance emergence, combination therapy) and in vivo (mouse gut colonization).
Main Results:
- Anti-Kd phages demonstrated a broad host range, infecting noncapsulated mutants from multiple Kp groups.
- These phages exhibited lower in vitro resistance emergence compared to traditional anti-K phages.
- Combination therapy with anti-Kd and anti-K phages showed increased killing efficiency.
- In vivo studies confirmed anti-Kd phage replication in mouse guts, indicating the presence of noncapsulated Kp.
Conclusions:
- A novel strategy using capsule-deficient mutants successfully isolated broad-spectrum anti-Kp phages.
- Anti-Kd phages circumvent the capsule barrier, offering a promising therapeutic avenue.
- These phages hold potential for decolonization and treatment of Kp infections, especially in combination therapy.
Related Concept Videos
Lytic Cycle of Bacteriophages
Lysogenic Cycle of Bacteriophages
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
DNA Bacteriophages
Viral Replication: Lysogenic Cycle
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...

